Fate Therapeutics, Inc.盘中异动股价大涨7.30%报1.47美元

市场透视2025-04-23

北京时间2025年04月23日21时30分，Fate Therapeutics, Inc.（FATE.us）股票出现异动，股价大幅拉升7.30%。截至发稿，该股报1.47美元/股，成交量6.135万股，换手率0.05%，振幅2.18%。最近的财报数据显示，该股实现营业收入13.63百万美元，净利润-1.86亿美元，每股收益-1.64美元，毛利-5.33百万美元，市盈率-0.85倍。机构评级方面，在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2529682249?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-23 21:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2529682249","market":"us","top_or_hot":-1,"title":"Fate Therapeutics, Inc.盘中异动 股价大涨7.30%报1.47美元","media":"市场透视","content":"<div>\n<p>北京时间2025年04月23日21时30分，Fate Therapeutics, Inc.（FATE.us）股票出现异动，股价大幅拉升7.30%。截至发稿，该股报1.47美元/股，成交量6.135万股，换手率0.05%，振幅2.18%。最近的财报数据显示，该股实现营业收入13.63百万美元，净利润-1.86亿美元，每股收益-1.64美元，毛利-5.33百万美元，市盈率-0.85倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213059a463f8f0&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fate Therapeutics, Inc.盘中异动 股价大涨7.30%报1.47美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFate Therapeutics, Inc.盘中异动 股价大涨7.30%报1.47美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-23 21:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213059a463f8f0&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年04月23日21时30分，Fate Therapeutics, Inc.（FATE.us）股票出现异动，股价大幅拉升7.30%。截至发稿，该股报1.47美元/股，成交量6.135万股，换手率0.05%，振幅2.18%。最近的财报数据显示，该股实现营业收入13.63百万美元，净利润-1.86亿美元，每股收益-1.64美元，毛利-5.33百万美元，市盈率-0.85倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213059a463f8f0&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FATE","symbol_name":"Fate Therapeutics Inc","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213059a463f8f0&s=b","article_id":"2529682249","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213059a463f8f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2529682249","pubTimestamp":1745415059,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年04月23日21时30分，Fate Therapeutics, Inc.股票出现异动，股价大幅拉升7.30%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ensysce Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Rezolute, Inc.涨幅较大，Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为2743.21%、17.71%、7.88%，振幅较大的相关个股有Psyence Biomedical Ltd.、Immunocore Hldgs Plc、Ocean Biomedical, Inc.，振幅分别为9.34%、8.64%、7.79%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"FATE":"Fate Therapeutics Inc","LENZ":"Therapeutics","BK4139":"生物科技","BK4007":"制药"},"translate_title":"Fate Therapeutics, Inc. shares jumped 7.30% to $1.47 in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FATE":0.9,"LENZ":1},"content_text":"北京时间2025年04月23日21时30分，Fate Therapeutics, Inc.（FATE.us）股票出现异动，股价大幅拉升7.30%。截至发稿，该股报1.47美元/股，成交量6.135万股，换手率0.05%，振幅2.18%。最近的财报数据显示，该股实现营业收入13.63百万美元，净利润-1.86亿美元，每股收益-1.64美元，毛利-5.33百万美元，市盈率-0.85倍。机构评级方面，在所有12家参与评级的机构中，33%的券商给予买入建议，67%的券商给予持有建议，无券商给予卖出建议。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ensysce Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)、Rezolute, Inc.涨幅较大，Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为2743.21%、17.71%、7.88%，振幅较大的相关个股有Psyence Biomedical Ltd.、Immunocore Hldgs Plc、Ocean Biomedical, Inc.，振幅分别为9.34%、8.64%、7.79%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。该公司致力于开发针对癌症和自身免疫性疾病的程序化细胞免疫疗法。该公司的细胞治疗产品线包括NK细胞和T细胞免疫肿瘤学项目，包括源自克隆主iPSC细胞系的现成工程候选产品，以及免疫调节项目，包括预防患者危及生命的并发症的候选产品。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2529682249","isCrawlerRequest":true}

Fate Therapeutics, Inc.盘中异动 股价大涨7.30%报1.47美元

精彩评论

Fate Therapeutics, Inc.盘中异动股价大涨7.30%报1.47美元